Alpha 2.0
Login Register
» Authors » Morton Leibowitz

Morton Leibowitz

Explore the profile of Morton Leibowitz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 423
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Public Health
Top 10 Co-Authors
Orna Reges
Moshe Hoshen
Ran D Balicer
Morris Mosseri
Noa Vilchinsky
Moti Haim
Ran Balicer
Adi Berliner Senderey
Jeremy D Kark
Philip Greenland
Published In
Int J Cardiol
Eur J Prev Cardiol
JAMA Intern Med
Am J Med
Obes Surg
Affiliations
Soon will be listed here.
Recent Articles
1.
Identifying patients with atrial fibrillation with a single CHADS-VASC risk factor who are at higher risk of stroke
Arnson Y, Berliner Senderey A, Hoshen M, Reges O, Balicer R, Alnsasra H, et al.
Ir J Med Sci . 2021 Apr; 191(2):705-711. PMID: 33843031
Aims: Management of patients with a single CHADS-VASc score risk factor is controversial. We attempt to identify the "truly low risk" AF patients who will not benefit from oral anticoagulation...
2.
Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database
Reges O, Dicker D, Haase C, Finer N, Karpati T, Leibowitz M, et al.
Obes Sci Pract . 2021 Apr; 7(2):148-158. PMID: 33841884
Objective: Previous studies using longitudinal weight data to characterize obesity are based on populations of limited size and mostly include individuals of all body mass index (BMI) levels, without focusing...
3.
Behavior and knowledge trajectories among adult offspring of patients with an acute cardiac event: A call for a turning point in cardiac prevention
Vilchinsky N, Nudelman-Rivkin K, Lambez B, Tuval Maschiach R, Leibowitz M, Mosseri M
Fam Syst Health . 2021 Feb; 38(4):359-368. PMID: 33591780
Introduction: Early detection is critical in the prevention of cardiovascular disease (CVD). An at-risk population for cardiac disease-and conveniently approachable in terms of timing-is cardiac patients' offspring, at the moment...
4.
Addressing bias in prediction models by improving subpopulation calibration
Barda N, Yona G, Rothblum G, Greenland P, Leibowitz M, Balicer R, et al.
J Am Med Inform Assoc . 2020 Nov; 28(3):549-558. PMID: 33236066
Objective: To illustrate the problem of subpopulation miscalibration, to adapt an algorithm for recalibration of the predictions, and to validate its performance. Materials And Methods: In this retrospective cohort study,...
5.
Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality
Lavie G, Hoshen M, Leibowitz M, Benis A, Akriv A, Balicer R, et al.
Am J Med . 2020 Nov; 134(5):643-652. PMID: 33217370
Purpose: This study assessed associations of the use of statins for primary prevention with cardiovascular outcomes among adults ages ≥70 years. Methods: In a retrospective population-based cohort study, new users...
6.
All-Cause Mortality of Patients With and Without Diabetes Following Bariatric Surgery: Comparison to Non-surgical Matched Patients
Dicker D, Greenland P, Leibowitz M, Hoshen M, Berliner Senderey A, Rasmussen-Torvik L, et al.
Obes Surg . 2020 Nov; 31(2):755-762. PMID: 33150480
Objective: Data are sparse regarding the survival benefit of bariatric surgery on mortality among persons with diabetes. We aimed to investigate the association of bariatric surgery, compared with usual care,...
7.
A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database
Reges O, Leibowitz M, Hirsch A, Dicker D, Finer N, Haase C, et al.
Isr J Health Policy Res . 2020 Jun; 9(1):32. PMID: 32580788
Background: The growing prevalence of obesity and its complications pose a huge burden on the individual and health care systems worldwide. This study presents the frequency of multiple prevalent co-morbidities...
8.
Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study
Reges O, Weinberg H, Hoshen M, Greenland P, Rayyan-Assi H, Tsadok M, et al.
Clin Epidemiol . 2020 Jun; 12:477-483. PMID: 32547239
Purpose: Previous studies have demonstrated differences in atrial fibrillation (AF) detection based on data from hospital sources without data from outpatient sources. We investigated the detection of documented diagnoses of...
9.
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study
Kezerle L, Tsadok M, Berliner Senderey A, Hoshen M, Leventer-Roberts M, Reges O, et al.
J Cardiovasc Electrophysiol . 2020 Mar; 31(6):1356-1363. PMID: 32212197
Introduction: Oral anticoagulation (OAC) therapy reduces the risk of ischemic stroke in patients with atrial fibrillation (AF) while increasing the risk of bleeding. Recently, non-vitamin K antagonist oral anticoagulants (NOACs)...
10.
Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
Arnson Y, Hoshen M, Berliner-Sendrey A, Reges O, Balicer R, Leibowitz M, et al.
Cardiology . 2020 Jan; 145(3):178-186. PMID: 31955174
Introduction: Atrial fibrillation (AF) and chronic kidney disease (CKD) are both associated with increased risk of stroke, and CKD carries a higher bleeding risk. Oral anticoagulation (OAC) treatment is used...